The Use of Coenzyme Q10 in Cardiovascular Diseases

The Use of Coenzyme Q10 in Cardiovascular Diseases Yoana Rabanal-Ruiz Emilio Llanos-González Francisco Javier Alcain http://orcid.org/0000-0002-6833-7940

CoQ10 is an endogenous antioxidant produced in all cells that plays an essential role in energy metabolism and antioxidant protection. CoQ10 distribution is not uniform among different organs, and the highest concentration is observed in the heart, though its levels decrease with age. Advanced age is the major risk factor for cardiovascular disease and endothelial dysfunction triggered by oxidative stress that impairs mitochondrial bioenergetic and reduces NO bioavailability, thus affecting vasodilatation. The rationale of the use of CoQ10 in cardiovascular diseases is that the loss of contractile function due to an energy depletion status in the mitochondria and reduced levels of NO for vasodilatation has been associated with low endogenous CoQ10 levels. Clinical evidence shows that CoQ10 supplementation for prolonged periods is safe, well-tolerated and significantly increases the concentration of CoQ10 in plasma up to 3–5 µg/mL. CoQ10 supplementation reduces oxidative stress and mortality from cardiovascular causes and improves clinical outcome in patients undergoing coronary artery bypass graft surgery, prevents the accumulation of oxLDL in arteries, decreases vascular stiffness and hypertension, improves endothelial dysfunction by reducing the source of ROS in the vascular system and increases the NO levels for vasodilation.
05 10 2021 755 antiox10050755 Consejería de Educación de la Junta de Comunidades de Castilla-La Mancha http://dx.doi.org/10.13039/ SBPLY/19/180501/000245 2020-GRIN-29101 https://creativecommons.org/licenses/by/4.0/ 10.3390/antiox10050755 https://www.mdpi.com/2076-3921/10/5/755 https://www.mdpi.com/2076-3921/10/5/755/pdf 10.1093/eurheartj/ehw334 10.1016/j.tibtech.2017.07.004 10.1016/j.jacc.2017.01.064 10.3390/ijms19020481 10.1016/j.exger.2017.06.007 10.1007/s00109-010-0663-9 10.1016/j.ijcard.2010.08.008 10.3389/fphys.2018.00044 10.1016/j.cca.2015.08.002 10.1073/pnas.82.3.901 10.1016/S0098-2997(97)00006-X 10.1016/j.jtcvs.2004.03.034 10.1016/j.jchf.2014.06.008 10.1097/JIM.0000000000000202 10.5603/CJ.a2019.0022 10.1016/j.ijcard.2012.04.156 10.1371/journal.pone.0141641 10.1371/journal.pone.0157541 10.1016/j.jtemb.2020.126541 10.1016/j.atherosclerosis.2011.02.013 10.1002/biof.1404 10.1016/j.nut.2012.03.016 10.1159/000445359 10.1089/jmf.2010.1202 10.1007/BF00226859 10.1016/j.hlc.2006.01.008 10.1053/j.jvca.2008.03.007 10.1111/1755-5922.12195 10.1093/icvts/ivu334 10.1016/j.avsg.2019.09.017 10.1016/j.mayocp.2014.08.021 10.1161/JAHA.118.009835 10.2147/DDDT.S223153 10.4103/0975-3583.98883 10.3390/biom9100553 10.4103/JLP.JLP_123_19 10.1016/j.biopha.2018.06.076 10.1139/apnm-2018-0488 10.1017/S0007114518001241 10.1007/s40256-019-00384-y 10.1002/edm2.118 10.3390/nu12041098 10.1074/jbc.M004128200 Luna-Sánchez Antioxidant Potential of Coenzyme Q10 Coenzyme Q10 from Fact to Fiction 2015 10.1080/07315724.2001.10719063 10.1016/0014-5793(91)80720-N 10.1073/pnas.86.16.6377 10.1073/pnas.88.5.1646 10.1074/jbc.M210456200 10.1023/A:1005568132027 Sohal Coenzyme Q and vitamin E interactions Methods Enzymol. 2004 10.1016/S0076-6879(04)78010-6 378 146 10.1016/0304-4165(91)90146-8 10.1073/pnas.92.11.4887 10.1016/S0891-5849(00)00307-5 10.1517/13543781003727495 10.1016/j.cccn.2004.04.003 10.3164/jcbn.15-73 10.1016/j.bbamem.2003.11.012 10.1002/cpdd.73 10.1186/s12986-019-0418-8 10.1016/j.jacc.2008.07.044 10.1002/14651858.CD008684.pub2 10.1161/CIRCRESAHA.111.246140 10.1007/s00125-012-2495-3 10.1161/01.RES.0000100665.67510.F5 10.1111/j.1468-2494.2012.00713.x 10.1100/2012/792756 10.1016/j.ejphar.2012.12.027 10.1016/j.molmet.2013.09.004 10.1016/j.mcn.2018.06.005 10.1093/oxfordjournals.aje.a117315 10.1016/j.atherosclerosis.2011.04.034 10.1016/j.clinbiochem.2004.02.008 10.1016/j.mito.2007.02.005 10.1097/MD.0000000000004501 10.3390/antiox10020276 10.1038/s41569-018-0098-5 10.1016/j.phrs.2015.07.008 10.1186/s40001-018-0353-6 10.1016/j.jacc.2007.02.049 10.1161/CIRCRESAHA.114.302721 10.1161/CIRCRESAHA.116.306534 10.1002/biof.5520090216 10.1016/S0891-5849(00)00311-7 10.1161/ATVBAHA.113.302879 10.1002/mnfr.201500186 10.1016/j.freeradbiomed.2017.02.049 10.1016/j.mvr.2018.03.012 10.1089/ars.2013.5566 10.1074/jbc.M302227200 10.1016/j.vph.2012.02.004 10.1074/jbc.272.2.1276 10.1172/JCI66843 Konukoglu Endothelial Dysfunction and Hypertension Adv. Exp. Med. Biol. 2017 10.1007/5584_2016_90 956 511 10.1155/2016/3527579 10.1159/000441091 10.1080/10715760701481461 10.1074/jbc.R700045200 10.1152/ajpheart.00537.2009 10.1590/S0074-02762005000900016 10.1161/01.RES.86.5.494 10.1681/ASN.V11101819 10.2337/diabetes.52.11.2795 10.1371/journal.pone.0109223 10.1155/2018/3181759 10.1155/2016/6384759 10.1002/mnfr.201100147 10.1016/j.jnutbio.2011.01.011 10.3389/fphar.2020.01034 10.1016/j.ejphar.2016.11.019 10.1038/sj.bjp.0701970 10.1038/srep30301